{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T00:56:39Z","timestamp":1781744199801,"version":"3.54.5"},"reference-count":100,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2022\\u202F M721060"],"award-info":[{"award-number":["2022\\u202F M721060"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.bioorg.2024.107698","type":"journal-article","created":{"date-parts":[[2024,8,6]],"date-time":"2024-08-06T13:13:03Z","timestamp":1722949983000},"page":"107698","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Targeting histone methylation and demethylation for non-alcoholic fatty liver disease"],"prefix":"10.1016","volume":"151","author":[{"given":"Yuanbing","family":"Du","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhangxu","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sasa","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaiyue","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feifei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingyu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.bioorg.2024.107698_b0005","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.3390\/ijms17091379","article-title":"Micronutrient antioxidants and nonalcoholic fatty liver disease","volume":"17","author":"Chen","year":"2016","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.bioorg.2024.107698_b0010","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/s41575-020-00406-0","article-title":"Nonalcoholic fatty liver disease: another leap forward","volume":"18","author":"MAbdelmalek","year":"2021","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"10","key":"10.1016\/j.bioorg.2024.107698_b0015","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1016\/j.cell.2021.04.015","article-title":"Mechanisms and disease consequences of nonalcoholic fatty liver disease","volume":"184","author":"Loomba","year":"2021","journal-title":"Cell."},{"key":"10.1016\/j.bioorg.2024.107698_b0020","doi-asserted-by":"crossref","first-page":"1130890","DOI":"10.3389\/fmed.2023.1130890","article-title":"A continuous-time markov chain model of fibrosis progression in NAFLD and NASH","volume":"10","author":"Meyer","year":"2023","journal-title":"Front Med (lausanne)."},{"issue":"4","key":"10.1016\/j.bioorg.2024.107698_b0025","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1080\/17474124.2020.1736042","article-title":"The effects of epigenetic modification on the occurrence and progression of liver diseases and the involved mechanism","volume":"14","author":"Chen","year":"2020","journal-title":"Expert. Rev. Gastroenterol. Hepatol."},{"issue":"12","key":"10.1016\/j.bioorg.2024.107698_b0030","doi-asserted-by":"crossref","first-page":"2718","DOI":"10.2337\/db09-1003","article-title":"Epigenetics: a molecular link between environmental factors and type 2 diabetes","volume":"58","author":"Ling","year":"2009","journal-title":"Diabetes."},{"issue":"6","key":"10.1016\/j.bioorg.2024.107698_b0035","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s12374-018-0176-6","article-title":"The regulation and function of histone methylation","volume":"61","author":"Niu","year":"2018","journal-title":"J. Plant Biol."},{"issue":"11","key":"10.1016\/j.bioorg.2024.107698_b0040","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1038\/nsmb1337","article-title":"Covalent modifications of histones during development and disease pathogenesis","volume":"14","author":"Bhaumik","year":"2007","journal-title":"Nat. Struct. Mol. Biol."},{"issue":"2","key":"10.1016\/j.bioorg.2024.107698_b0045","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/nri2487","article-title":"Epigenetic control of T-helper-cell differentiation","volume":"9","author":"Wilson","year":"2009","journal-title":"Nat. Rev. Immunol."},{"issue":"10","key":"10.1016\/j.bioorg.2024.107698_b0050","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1038\/aps.2016.64","article-title":"Histone lysine methyltransferases as anti-cancer targets for drug discovery","volume":"37","author":"Liu","year":"2016","journal-title":"Acta. Pharmacol. Sin."},{"issue":"5","key":"10.1016\/j.bioorg.2024.107698_b0055","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1038\/nrd3674","article-title":"Epigenetic protein families: a new frontier for drug discovery","volume":"11","author":"Arrowsmith","year":"2012","journal-title":"Nat. Rev. Drug Discov."},{"issue":"9","key":"10.1016\/j.bioorg.2024.107698_b0060","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1038\/nrd2974","article-title":"Protein methyltransferases as a target class for drug discovery","volume":"8","author":"Copeland","year":"2009","journal-title":"Nat. Rev. Drug Discov."},{"issue":"1","key":"10.1016\/j.bioorg.2024.107698_b0065","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1146\/annurev-biochem-061809-175347","article-title":"Signals and combinatorial functions of histone modifications","volume":"80","author":"Suganuma","year":"2011","journal-title":"Annu. Rev. Biochem."},{"issue":"5","key":"10.1016\/j.bioorg.2024.107698_b0070","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/nrn2132","article-title":"Epigenetic regulation in psychiatric disorders","volume":"8","author":"Tsankova","year":"2007","journal-title":"Nat. Rev. Neurosci."},{"issue":"5701","key":"10.1016\/j.bioorg.2024.107698_b0075","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1126\/science.1100576","article-title":"Chromatin Compaction by a Polycomb Group Protein Complex","volume":"306","author":"Francis","year":"2004","journal-title":"Sci."},{"issue":"8","key":"10.1016\/j.bioorg.2024.107698_b0080","doi-asserted-by":"crossref","first-page":"e104776","DOI":"10.1371\/journal.pone.0104776","article-title":"Polycomb Group Protein Ezh2 Regulates Hepatic Progenitor Cell Proliferation and Differentiation in Murine Embryonic Liver","volume":"9","author":"Koike","year":"2014","journal-title":"PLoS One."},{"issue":"5","key":"10.1016\/j.bioorg.2024.107698_b0085","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/ni.3125","article-title":"I-hsin Su, The methyltransferase Ezh2 controls cell adhesion and migration through direct methylation of the extranuclear regulatory protein talin","volume":"16","author":"Gunawan","year":"2015","journal-title":"Nat. Immunol."},{"issue":"6","key":"10.1016\/j.bioorg.2024.107698_b0090","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.ccr.2013.04.008","article-title":"Phosphorylation of EZH2 activates STAT3 signaling via STAT3 methylation and promotes tumorigenicity of glioblastoma stem-like cells","volume":"23","author":"Kim","year":"2013","journal-title":"Cancer Cell."},{"issue":"3","key":"10.1016\/j.bioorg.2024.107698_b0095","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.cell.2005.02.029","article-title":"Polycomb group protein ezh2 controls actin polymerization and cell signaling","volume":"121","author":"Su","year":"2005","journal-title":"Cell."},{"issue":"4","key":"10.1016\/j.bioorg.2024.107698_b0100","first-page":"619","article-title":"A non-canonical function of Ezh2 preserves immune homeostasis, EMBO","volume":"18","author":"Vasanthakumar","year":"2017","journal-title":"Rep."},{"issue":"12","key":"10.1016\/j.bioorg.2024.107698_b0105","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1111\/febs.13665","article-title":"TGF-\u03b2 signalling and liver disease","volume":"283","author":"I. Fabregat, J.M. C\u00e0ceres, A. S\u00e1nchez, S. Dooley, B. Dewidar, G. Giannelli, P.T. Dijke, I.L. Consortium","year":"2016","journal-title":"FEBS J."},{"issue":"1","key":"10.1016\/j.bioorg.2024.107698_b0110","doi-asserted-by":"crossref","first-page":"2823","DOI":"10.1038\/ncomms3823","article-title":"Fate tracing reveals hepatic stellate cells as dominant contributors to liver fibrosis independent of its aetiology","volume":"4","author":"Mederacke","year":"2013","journal-title":"Nat. Commun."},{"issue":"14","key":"10.1016\/j.bioorg.2024.107698_b0115","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1056\/NEJM199104043241401","article-title":"Transforming growth factors beta 1 and alpha in chronic liver disease. Effects ofinterferon alfa therapy","volume":"324","author":"Castilla","year":"1991","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.bioorg.2024.107698_b0120","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.jcmgh.2018.09.005","article-title":"Enhancer of zeste homologue 2 inhibition attenuates TGF-\u03b2 dependent hepatic stellate cell activation and liver fibrosis","volume":"7","author":"Mateos","year":"2019","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"issue":"7","key":"10.1016\/j.bioorg.2024.107698_b0125","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1136\/gut.2010.231993","article-title":"EZH2 protein: a promising immunomarker for the detection of hepatocellular carcinomas in liver needle biopsies","volume":"60","author":"Cai","year":"2011","journal-title":"Gut."},{"issue":"2","key":"10.1016\/j.bioorg.2024.107698_b0130","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1002\/hep.25679","article-title":"Enhancer of zeste homolog 2 epigenetically silences multiple tumor suppressor microRNAs to promote liver cancer metastasis","volume":"56","author":"Au","year":"2012","journal-title":"Hepatology."},{"issue":"1","key":"10.1016\/j.bioorg.2024.107698_b0135","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s13046-017-0670-6","article-title":"EZH2 promotes hepatocellular carcinoma progression through modulating miR-22\/galectin-9 axis","volume":"37","author":"Chen","year":"2018","journal-title":"J. Exp. Clin. Cancer. Res."},{"issue":"5","key":"10.1016\/j.bioorg.2024.107698_b0140","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1016\/j.jhep.2014.11.040","article-title":"A CCRK-EZH2 epigenetic circuitry drives hepatocarcinogenesis and associates with tumor recurrence and poor survival of patients","volume":"62","author":"Feng","year":"2015","journal-title":"J. Hepatol."},{"issue":"10","key":"10.1016\/j.bioorg.2024.107698_b0145","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1111\/jcmm.13153","article-title":"EZH2-mediated repression of Dkk1 promotes hepatic stellate cell activation and hepatic fibrosis","volume":"21","author":"Yang","year":"2017","journal-title":"J. Cell. Mol. Med."},{"issue":"6","key":"10.1016\/j.bioorg.2024.107698_b0150","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1021\/cb400133j","article-title":"An orally bioavailable chemical probe of the lysine methyltransferases EZH2 and EZH1","volume":"8","author":"Konze","year":"2013","journal-title":"ACS. Chem. Biol."},{"issue":"1","key":"10.1016\/j.bioorg.2024.107698_b0155","doi-asserted-by":"crossref","first-page":"9","DOI":"10.18632\/oncoscience.285","article-title":"In silico and experimental analyses predict the therapeutic value of an EZH2 inhibitor GSK343 against hepatocellular carcinoma through the induction of metallothionein genes","volume":"3","author":"Liu","year":"2016","journal-title":"Oncoscience."},{"issue":"7427","key":"10.1016\/j.bioorg.2024.107698_b0160","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/nature11606","article-title":"EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutations","volume":"492","author":"McCabe","year":"2012","journal-title":"Nature."},{"issue":"6","key":"10.1016\/j.bioorg.2024.107698_b0165","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1038\/s41419-018-0670-2","article-title":"Enhancer of zeste homolog 2-catalysed H3K27 trimethylation plays a key role in acute-on-chronic liver failure via TNF-mediated pathway","volume":"9","author":"Zhou","year":"2018","journal-title":"Cell. Death. Dis."},{"issue":"19","key":"10.1016\/j.bioorg.2024.107698_b0170","doi-asserted-by":"crossref","first-page":"7922","DOI":"10.1073\/pnas.1303800110","article-title":"Durable tumor regression in genetically altered malignant rhabdoid tumors by inhibition of methyltransferase EZH2","volume":"110","author":"Knutson","year":"2013","journal-title":"Proc. Natl. Acad. Sci. u. s. a."},{"issue":"5","key":"10.1016\/j.bioorg.2024.107698_b0175","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1007\/s40265-020-01288-x","article-title":"Tazemetostat: First Approval","volume":"80","author":"Hoy","year":"2020","journal-title":"Drugs."},{"issue":"5","key":"10.1016\/j.bioorg.2024.107698_b0180","doi-asserted-by":"crossref","first-page":"93","DOI":"10.3390\/biology9050093","article-title":"The role of the histone methyltransferase EZH2 in liver inflammation and fibrosis in STAM NASH mice","volume":"9","author":"Lee","year":"2020","journal-title":"Biology."},{"issue":"11","key":"10.1016\/j.bioorg.2024.107698_b0185","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1016\/j.bmcl.2014.04.010","article-title":"Biological evaluation of tanshindiols as EZH2 histone methyltransferase inhibitors","volume":"24","author":"Woo","year":"2014","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"9","key":"10.1016\/j.bioorg.2024.107698_b0190","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1002\/ptr.5659","article-title":"Treatment of non-alcoholic fatty liver disease with curcumin: a randomized placebo-controlled trial","volume":"30","author":"Rahmani","year":"2016","journal-title":"Phytother. Res."},{"issue":"12","key":"10.1016\/j.bioorg.2024.107698_b0195","doi-asserted-by":"crossref","first-page":"8121","DOI":"10.1074\/jbc.M114.548651","article-title":"3-Deazaneplanocin A (DZNep), an inhibitor of S-adenosylmethionine-dependent methyltransferase, promotes erythroid differentiation","volume":"289","author":"Fujiwara","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bioorg.2024.107698_b0200","doi-asserted-by":"crossref","first-page":"e11374","DOI":"10.7717\/peerj.11374","article-title":"DZNep, an inhibitor of the histone methyltransferase EZH2, suppresses hepatic fibrosis through regulating miR-199a-5p\/SOCS7 pathway","volume":"9","author":"Ding","year":"2021","journal-title":"PeerJ."},{"issue":"1","key":"10.1016\/j.bioorg.2024.107698_b0205","doi-asserted-by":"crossref","first-page":"361","DOI":"10.7150\/thno.46360","article-title":"Histone H3K27 methyltransferase EZH2 and demethylase JMJD3 regulate hepatic stellate cells activation and liver fibrosis","volume":"11","author":"Jiang","year":"2021","journal-title":"Theranostics."},{"issue":"4","key":"10.1016\/j.bioorg.2024.107698_b0210","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1523\/JNEUROSCI.2584-09.2010","article-title":"1BAMBI (bone morphogenetic protein and activin membrane-bound inhibitor) reveals the involvement of the transforming growth factor-\u03b2 family in pain modulation","volume":"30","author":"Tramullas","year":"2010","journal-title":"J. Neurosci."},{"issue":"5","key":"10.1016\/j.bioorg.2024.107698_b0215","doi-asserted-by":"crossref","first-page":"2797","DOI":"10.1093\/nar\/gkt012","article-title":"Histone H4 Lysine 20 methylation: key player in epigenetic regulation of genomic integrity","volume":"41","author":"Jorgensen","year":"2013","journal-title":"Nucleic. Acids. Res."},{"issue":"22","key":"10.1016\/j.bioorg.2024.107698_b0220","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.1101\/gad.1984210","article-title":"Dynamic regulation of the PR-Set7 histone methyltransferase is required for normal cell cycle progression","volume":"24","author":"Wu","year":"2010","journal-title":"Genes. Dev."},{"issue":"7","key":"10.1016\/j.bioorg.2024.107698_b0225","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1083\/jcb.200706150","article-title":"The histone methyltransferase SET8 is required for S-phase progression","volume":"179","author":"J\u00f8rgensen","year":"2007","journal-title":"J. Cell Biol."},{"issue":"8","key":"10.1016\/j.bioorg.2024.107698_b0230","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.1128\/MCB.01768-08","article-title":"Monomethylation of histone H4-lysine 20 is involved in chromosome structure and stability and is essential for mouse development","volume":"29","author":"Oda","year":"2009","journal-title":"Mol. Cell Biol."},{"issue":"4","key":"10.1016\/j.bioorg.2024.107698_b0235","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.molcel.2007.07.012","article-title":"Modulation of p53 function by SET8-mediated methylation at lysine 382","volume":"27","author":"Shi","year":"2007","journal-title":"Mol. Cell."},{"issue":"13","key":"10.1016\/j.bioorg.2024.107698_b0240","doi-asserted-by":"crossref","first-page":"3217","DOI":"10.1158\/0008-5472.CAN-11-3701","article-title":"Histone lysine methyltransferase SETD8 promotes carcinogenesis by deregulating PCNA expression","volume":"72","author":"Takawa","year":"2012","journal-title":"Cancer Res."},{"issue":"3","key":"10.1016\/j.bioorg.2024.107698_b0245","first-page":"3665","article-title":"Prognostic impact of SET domain-containing protein 8 and protein arginine methyltransferase 5 in patients with hepatocellular carcinoma following curative resection","volume":"16","author":"Lin","year":"2018","journal-title":"Oncol. Lett."},{"issue":"15","key":"10.1016\/j.bioorg.2024.107698_b0250","doi-asserted-by":"crossref","first-page":"6822","DOI":"10.1021\/jm500871s","article-title":"Discovery of a selective, substrate-competitive inhibitor of the lysine methyltransferase SETD8","volume":"57","author":"Ma","year":"2014","journal-title":"J. Med. Chem."},{"issue":"1","key":"10.1016\/j.bioorg.2024.107698_b0255","doi-asserted-by":"crossref","first-page":"4490","DOI":"10.1038\/s41598-020-61402-7","article-title":"Downregulation of histone methyltransferase SET8 inhibits progression of hepatocellular carcinoma","volume":"10","author":"Wu","year":"2020","journal-title":"Sci. Rep."},{"issue":"7719","key":"10.1016\/j.bioorg.2024.107698_b0260","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1038\/s41586-018-0398-2","article-title":"Automethylation-induced conformational switch in Clr4 (Suv39h) maintains epigenetic stability","volume":"560","author":"Iglesias","year":"2018","journal-title":"Nature."},{"issue":"6","key":"10.1016\/j.bioorg.2024.107698_b0265","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1002\/hep.29127","article-title":"The histone methyltransferase Suv39h2 contributes to nonalcoholic steatohepatitis in mice","volume":"65","author":"Fan","year":"2017","journal-title":"Hepatology."},{"issue":"1","key":"10.1016\/j.bioorg.2024.107698_b0270","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/hep.24010","article-title":"Antihepatoma activity of chaetocin due to deregulated splicing of hypoxia-inducible factor 1alpha pre-mRNA in mice and in vitro","volume":"53","author":"Lee","year":"2011","journal-title":"Hepatology."},{"issue":"42","key":"10.1016\/j.bioorg.2024.107698_b0275","doi-asserted-by":"crossref","first-page":"16746","DOI":"10.1021\/ja206312b","article-title":"Selective inhibitors of histone methyltransferase DOT1L: design, synthesis, and crystallographic studies","volume":"133","author":"Yao","year":"2011","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.bioorg.2024.107698_b0280","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2023.102691","article-title":"STING mediates hepatocyte pyroptosis in liver fibrosis by Epigenetically activating the NLRP3 inflammasome","volume":"62","author":"Xiao","year":"2023","journal-title":"Redox. Biol."},{"issue":"6","key":"10.1016\/j.bioorg.2024.107698_b0285","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/s41575-018-0009-6","article-title":"Triggering and resolution of inflammation in NASH","volume":"15","author":"Schuster","year":"2018","journal-title":"Nat. Rev. Gastroenterol Hepatol."},{"issue":"3","key":"10.1016\/j.bioorg.2024.107698_b0290","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/s41575-020-00372-7","article-title":"Molecular and cellular mechanisms of liver fibrosis and its regression","volume":"18","author":"Kisseleva","year":"2021","journal-title":"Nat. Rev. Gastroenterol Hepatol."},{"issue":"5","key":"10.1016\/j.bioorg.2024.107698_b0295","first-page":"7864","article-title":"Effect of high WDR5 expression on the hepatocellular carcinoma prognosis","volume":"15","author":"Cui","year":"2018","journal-title":"Oncol. Lett."},{"issue":"3","key":"10.1016\/j.bioorg.2024.107698_b0300","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/j.apsb.2023.10.023","article-title":"Epigenetic modification in liver fibrosis: Promising therapeutic direction with significant challenges ahead","volume":"14","author":"Liu","year":"2024","journal-title":"Acta. Pharm. Sin. b."},{"key":"10.1016\/j.bioorg.2024.107698_b0305","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1476-4598-5-26","article-title":"Identification and characterization of Smyd2: a split SET\/MYND domain-containing histone H3 lysine 36-specific methyltransferase that interacts with the Sin3 histone deacetylase complex","volume":"5","author":"Brown","year":"2006","journal-title":"Mol. Cancer."},{"issue":"7119","key":"10.1016\/j.bioorg.2024.107698_b0310","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1038\/nature05287","article-title":"Repression of p53 activity by Smyd2-mediated methylation","volume":"444","author":"Huang","year":"2006","journal-title":"Nature."},{"issue":"6","key":"10.1016\/j.bioorg.2024.107698_b0315","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1593\/neo.12656","article-title":"RB1 methylation by SMYD2 enhances cell cycle progression through an increase of RB1 phosphorylation","volume":"14","author":"Ch","year":"2012","journal-title":"Neoplasia."},{"issue":"4","key":"10.1016\/j.bioorg.2024.107698_b0320","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.neo.2015.03.002","article-title":"Dysregulation of AKT pathway by SMYD2-mediated lysine methylation on PTEN","volume":"17","author":"Nakakido","year":"2015","journal-title":"Neoplasia."},{"issue":"3","key":"10.1016\/j.bioorg.2024.107698_b0325","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.neo.2014.03.002","article-title":"The histone methyltransferase SMYD2 methylates PARP1 and promotes poly(ADP-ribosyl)ation activity in cancer cells","volume":"16","author":"Piao","year":"2014","journal-title":"Neoplasia."},{"issue":"2","key":"10.1016\/j.bioorg.2024.107698_b0330","doi-asserted-by":"crossref","first-page":"321","DOI":"10.7150\/jca.22218","article-title":"Positive expression of SMYD2 is associated with poor prognosis in patients with primary hepatocellular carcinoma","volume":"9","author":"Zuo","year":"2018","journal-title":"J. Cancer."},{"issue":"22","key":"10.1016\/j.bioorg.2024.107698_b0335","doi-asserted-by":"crossref","first-page":"13641","DOI":"10.1074\/jbc.M114.626861","article-title":"LLY-507, a cell-active, potent, and selective inhibitor of protein-lysine methyltransferase SMYD2","volume":"290","author":"Nguyen","year":"2015","journal-title":"J. Biol. Chem."},{"issue":"12","key":"10.1016\/j.bioorg.2024.107698_b0340","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1021\/ml3003346","article-title":"Identification of potent, selective, cell-active inhibitors of the histone lysine methyltransferase EZH2","volume":"3","author":"Verma","year":"2012","journal-title":"ACS. Med. Chem. Lett."},{"issue":"3","key":"10.1016\/j.bioorg.2024.107698_b0345","doi-asserted-by":"crossref","first-page":"10.1002","DOI":"10.1002\/pbc.26218","article-title":"Initial testing (stage 1) of tazemetostat (EPZ-6438), a novel EZH2 inhibitor, by the pediatric preclinical testing program","volume":"64","author":"Kurmasheva","year":"2017","journal-title":"Pediatr. Blood. Cancer."},{"issue":"9","key":"10.1016\/j.bioorg.2024.107698_b0350","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1038\/nrg1945","article-title":"JmjC-domain-containing proteins and histone demethylation","volume":"7","author":"Klose","year":"2006","journal-title":"Nat. Rev. Genet."},{"issue":"5\u20136","key":"10.1016\/j.bioorg.2024.107698_b0355","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.cbpa.2012.09.015","article-title":"Mechanisms of human histone and nucleic acid demethylases","volume":"16","author":"Walport","year":"2012","journal-title":"Curr. Opin. Chem. Biol."},{"issue":"1","key":"10.1016\/j.bioorg.2024.107698_b0360","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1038\/s41420-023-01489-9","article-title":"Histone demethylases in the regulation of immunity and inflammation","volume":"9","author":"Qu","year":"2023","journal-title":"Cell. Death. Discov."},{"issue":"1","key":"10.1016\/j.bioorg.2024.107698_b0365","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s13277-012-0525-x","article-title":"Overexpression of LSD1 in hepatocellular carcinoma: a latent target for the diagnosis and therapy of hepatoma","volume":"34","author":"Zhao","year":"2013","journal-title":"Tumor. Biol."},{"issue":"6","key":"10.1016\/j.bioorg.2024.107698_b0370","doi-asserted-by":"crossref","first-page":"2992","DOI":"10.1172\/JCI128073","article-title":"Hepatic Slug epigenetically promotes liver lipogenesis, fatty liver disease, and type 2 diabetes","volume":"130","author":"Liu","year":"2020","journal-title":"J. Clin. Invest."},{"issue":"3","key":"10.1016\/j.bioorg.2024.107698_b0375","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.cell.2006.03.028","article-title":"Reversal of histone lysine trimethylation by the JMJD2 family of histone demethylases","volume":"125","author":"Whetstine","year":"2006","journal-title":"Cell."},{"issue":"6","key":"10.1016\/j.bioorg.2024.107698_b0380","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.tem.2014.04.001","article-title":"PPAR\u03b3 and the global map of adipogenesis and beyond","volume":"25","author":"Lefterova","year":"2014","journal-title":"Trends. Endocrinol. Metab."},{"issue":"11","key":"10.1016\/j.bioorg.2024.107698_b0385","doi-asserted-by":"crossref","first-page":"2759","DOI":"10.2337\/db07-0156","article-title":"Genes involved in fatty acid partitioning and binding, lipolysis, monocyte\/macrophage recruitment, and inflammation are overexpressed in the human fatty liver of insulin-resistant subjects","volume":"56","author":"Westerbacka","year":"2007","journal-title":"Diabetes."},{"issue":"1","key":"10.1016\/j.bioorg.2024.107698_b0390","doi-asserted-by":"crossref","first-page":"13734","DOI":"10.1038\/s41598-018-31953-x","article-title":"Histone H3K9 demethylase JMJD2B induces hepatic steatosis through upregulation of PPAR\u03b32","volume":"8","author":"Kim","year":"2018","journal-title":"Sci. Rep."},{"issue":"21","key":"10.1016\/j.bioorg.2024.107698_b0395","doi-asserted-by":"crossref","first-page":"8313","DOI":"10.3390\/ijms21218313","article-title":"Histone H3K9 demethylase JMJD2B plays a role in LXR\u03b1-dependent lipogenesis","volume":"21","author":"Kim","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.bioorg.2024.107698_b0400","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1016\/j.bbrc.2016.11.164","article-title":"Protective effects of gomisin N against hepatic steatosis through AMPK activation","volume":"482","author":"Yun","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"10.1016\/j.bioorg.2024.107698_b0405","doi-asserted-by":"crossref","first-page":"14538","DOI":"10.1038\/s41598-020-71403-1","article-title":"RFX5 promotes the progression of hepatocellular carcinoma through transcriptional activation of KDM4A","volume":"10","author":"Chen","year":"2020","journal-title":"Sci. Rep."},{"issue":"5","key":"10.1016\/j.bioorg.2024.107698_b0410","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1096\/fj.14-251751","article-title":"Histone H3K9 demethylase JMJD1A modulates hepatic stellate cells activation and liver fibrosis by epigenetically regulating peroxisome proliferator-activated receptor \u03b3","volume":"29","author":"Jiang","year":"2015","journal-title":"FASEB. J."},{"issue":"22","key":"10.1016\/j.bioorg.2024.107698_b0415","doi-asserted-by":"crossref","first-page":"7053","DOI":"10.1021\/jm800936s","article-title":"Inhibitor scaffolds for 2-oxoglutarate-dependent histone lysine demethylases","volume":"51","author":"Rose","year":"2008","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107698_b0420","first-page":"801","article-title":"Lysine-specific demethylase 5C promotes hepatocellular carcinoma cell invasion through inhibition BMP7 expression, BMC","volume":"15","author":"Ji1","year":"2015","journal-title":"Cancer."},{"issue":"5","key":"10.1016\/j.bioorg.2024.107698_b0425","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1002\/kjm2.12501","article-title":"Lysine demethylase 5C epigenetically reduces transcription of ITIH1 that results in augmented progression of liver hepatocellular carcinoma","volume":"38","author":"Qian","year":"2022","journal-title":"Kaohsiung. J. Med. Sci."},{"issue":"2","key":"10.1016\/j.bioorg.2024.107698_b0430","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1089\/nat.2019.0820","article-title":"Metabolic benefits of microRNA-22 inhibition","volume":"30","author":"Thibonnier","year":"2020","journal-title":"Nucleic. Acid. The."},{"issue":"10","key":"10.1016\/j.bioorg.2024.107698_b0435","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1007\/s00109-014-1182-x","article-title":"Histone demethylase Jumonji D3 (JMJD3\/KDM6B) at the nexus of epigenetic regulation of inflammation and the aging process","volume":"92","author":"Salminen","year":"2014","journal-title":"J. Mol. Med. (berl)"},{"key":"10.1016\/j.bioorg.2024.107698_b0440","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.neuint.2019.01.006","article-title":"The histone H3 Lys 27 demethylase KDM6B promotes migration and invasion of glioma cells partly by regulating the expression of SNAI1","volume":"124","author":"Sui","year":"2019","journal-title":"Neurochem. Int."},{"issue":"16","key":"10.1016\/j.bioorg.2024.107698_b0445","doi-asserted-by":"crossref","first-page":"12994","DOI":"10.1074\/jbc.M111.323105","article-title":"JMJD5, a Jumonji C (JmjC) domain-containing protein, negatively regulates osteoclastogenesis by facilitating NFATc1 protein degradation","volume":"287","author":"Youn","year":"2012","journal-title":"J. Biol. Chem."},{"issue":"21","key":"10.1016\/j.bioorg.2024.107698_b0450","doi-asserted-by":"crossref","first-page":"9671","DOI":"10.1073\/pnas.1000401107","article-title":"KDM8, a H3K36me2 histone demethylase that acts in the cyclin A1 coding region to regulate cancer cell proliferation","volume":"107","author":"Hsiaa","year":"2010","journal-title":"Proc. Natl. Acad Sci. u. s. a."},{"issue":"8","key":"10.1016\/j.bioorg.2024.107698_b0455","doi-asserted-by":"crossref","first-page":"2098","DOI":"10.1002\/stem.1724","article-title":"JMJD5 regulates cell cycle and pluripotency in human embryonic stem cells","volume":"32","author":"Zhu","year":"2014","journal-title":"Stem. Cells."},{"issue":"50","key":"10.1016\/j.bioorg.2024.107698_b0460","doi-asserted-by":"crossref","first-page":"21623","DOI":"10.1073\/pnas.1014204108","article-title":"Jumonji domain protein JMJD5 functions in both the plant and human circadian systems","volume":"107","author":"Jonesa","year":"2010","journal-title":"Proc. Natl. Acad. Sci. u. s. a."},{"issue":"6","key":"10.1016\/j.bioorg.2024.107698_b0465","doi-asserted-by":"crossref","first-page":"6847","DOI":"10.18632\/oncotarget.6867","article-title":"Epigenetic silencing of JMJD5 promotes the proliferation of hepatocellular carcinoma cells by down-regulating the transcription of CDKN1A 686","volume":"7","author":"Wu","year":"2016","journal-title":"Oncotarget."},{"issue":"10","key":"10.1016\/j.bioorg.2024.107698_b0470","doi-asserted-by":"crossref","first-page":"734","DOI":"10.14348\/molcells.2014.0180","article-title":"The histone demethylase PHF2 promotes fat cell differentiation as an epigenetic activator of both C\/EBP\u03b1 and C\/EBP\u03b4","volume":"37","author":"Lee","year":"2014","journal-title":"Mol. Cells."},{"issue":"1","key":"10.1016\/j.bioorg.2024.107698_b0475","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1038\/s41467-018-04361-y","article-title":"The histone demethylase Phf2 acts as a molecular checkpoint to prevent NAFLD progression during obesity","volume":"9","author":"Bricambert","year":"2018","journal-title":"Nat. Commun."},{"issue":"7","key":"10.1016\/j.bioorg.2024.107698_b0480","doi-asserted-by":"crossref","first-page":"3144","DOI":"10.1172\/JCI97736","article-title":"Fasting-induced JMJD3 histone demethylase epigenetically activates mitochondrial fatty acid beta-oxidation","volume":"128","author":"Seok","year":"2018","journal-title":"J. Clin. Invest."},{"issue":"2","key":"10.1016\/j.bioorg.2024.107698_b0485","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1002\/lt.25003","article-title":"Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: Implications for liver transplantation","volume":"24","author":"Younossi","year":"2018","journal-title":"Liver. Transpl."},{"issue":"1","key":"10.1016\/j.bioorg.2024.107698_b0490","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease\u2014Meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology."},{"issue":"6","key":"10.1016\/j.bioorg.2024.107698_b0495","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1016\/j.celrep.2016.10.023","article-title":"Critical roles of the histone methyltransferase MLL4\/KMT2D in murine hepatic steatosis directed by ABL1 and PPAR\u03b32","volume":"17","author":"Kim","year":"2016","journal-title":"Cell. Rep."},{"issue":"2","key":"10.1016\/j.bioorg.2024.107698_b0500","article-title":"Epigenetic mechanisms and metabolic reprogramming in fibrogenesis: dual targeting of G9a and DNMT1 for the inhibition of liver fibrosis","volume":"70","author":"Varela","year":"2021","journal-title":"Gut."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206824006035?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206824006035?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T00:48:49Z","timestamp":1781743729000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206824006035"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":100,"alternative-id":["S0045206824006035"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2024.107698","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting histone methylation and demethylation for non-alcoholic fatty liver disease","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2024.107698","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"107698"}}